双侧胸廓内动脉搭桥时左前降支旁路的最佳构型
本研究比较双侧胸廓内动脉(BITA)搭桥中左胸廓内动脉(LITA)-左前降支(LAD)与右胸廓内动脉(RITA)-LAD构型的临床结局。主要结局为LAD区域需再次经皮或外科干预,次要结局为全因死亡和心源性死亡。结果显示两种构型在10年再次血运重建、调整生存率和心源性死亡上均无显著差异。
要点
- BITA搭桥中LITA-LAD与RITA-LAD的10年LAD再次血运重建率无显著差异。
- 两种构型的10年调整生存率和心源性死亡率均无显著差异。
- 心脏外科医生在BITA搭桥中使用RITA-LAD旁路应有信心。
核心结论
- BITA血运重建中采用LITA或RITA行LAD搭桥对长期全因死亡、心源性死亡及LAD再次血运重建需求均无影响。
研究设计与样本
- 回顾性比较研究,纳入BITA搭桥患者,其中LITA-LAD组1527例,RITA-LAD组523例。
- 采用Cox比例风险模型和竞争风险模型,并进行熵加权分析。
主要发现
- 熵加权前,RITA-LAD组患者年龄更大,糖尿病、外周血管病和左心室功能不全更多,急诊状态更多(P < .05),非体外循环手术更频繁(P < .001)。
- 10年LAD区域再次血运重建需求:LITA-LAD组2.8%,RITA-LAD组1.8%(亚风险比=0.686;95%CI 0.296-1.589;P = .38)。
- 10年调整生存率:LITA-LAD组97.2%,RITA-LAD组98.2%(风险比=1.056;95%CI 0.677-1.647;P = .81)。
- 心源性死亡无差异(亚风险比=1.063;95%CI 0.502-2.251;P = .87)。
临床怎么用
- 在BITA搭桥中,可依据解剖和临床情况选择RITA或LITA作为LAD旁路,两者长期结局相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The left internal thoracic artery (LITA) to left anterior descending (LAD) artery bypass remains the reference standard for coronary artery bypass graft surgery. With the advent of bilateral internal thoracic artery (BITA) grafting, optimal bypass configuration to the LAD is unclear. The objective of this study was to compare clinical outcomes between LITA-LAD and right internal thoracic artery (RITA)-LAD configurations in BITA grafting. METHODS: The primary outcome was the need for percutaneous or surgical reintervention of the LAD. Secondary outcomes included all-cause mortality and cardiac mortality. Cox proportional hazard and competing risk models were used with entropy weighting. RESULTS: Among BITA patients, 1527 had LITA-LAD grafts, and 523 RITA-LAD. Before entropy weighting, RITA-LAD patients were older with more diabetes, peripheral vascular disease, and left ventricular dysfunction, more urgent status (P < .05), and more frequently performed off-pump (P < .001). Need for repeat revascularization of the LAD territory at 10 years was 2.8% in the LITA-LAD group and 1.8% in the RITA-LAD group (subhazard ratio = 0.686; 95% confidence interval [CI], 0.296-1.589; P = .38). Adjusted survival at 10 years was 97.2% in the LITA-LAD group and 98.2% in the RITA-LAD group (hazard ratio = 1.056; 95% CI, 0.677-1.647; P = .81). There was no difference in cardiac mortality (subhazard ratio = 1.063; 95% CI, 0.502-2.251; P = .87). CONCLUSIONS: Use of either LITA or RITA for LAD grafting during BITA revascularization has no effect on long-term all-cause or cardiac mortality or need for repeat revascularization of the LAD. Cardiac surgeons should be confident in using a RITA-LAD bypass during BITA grafting.
引用
- Jabagi H, Tran D, Glineur D, et al. Optimal Configuration for Bypass of the Left Anterior Descending Artery During Bilateral Internal Thoracic Artery Grafting. Ann Thorac Surg. 2020. PMID: 32439394. doi:10.1016/j.athoracsur.2020.03.122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。